Rare renal proximal tubular dysfunctions in primary biliary cholangitis

References

• Kaplan MM, Gershwin ME. Primary biliary cirrhosis. N Engl J Med. 2005;353(12):1–10. doi: 10.1056/NEJMra043898.
   PubMed Web of Science ®Google Scholar
• Lindor KD, Bowlus CL, Boyer J, et al. Primary biliary cholangitis: 2018 practice guidance from the American association for the study of liver diseases. Hepatology. 2019;69(1):394–419. doi: 10.1002/hep.30145.
   PubMed Web of Science ®Google Scholar
• EASL clinical practice guidelines: the diagnosis and management of patients with primary biliary cholangitis. J Hepatol. 2017;67:145–172.
   PubMed Web of Science ®Google Scholar
• Floreani A, Franceschet I, Cazzagon N, et al. Extrahepatic autoimmune conditions associated with primary biliary cirrhosis. Clin Rev Allergy Immunol. 2015;48(2-3):192–197. doi: 10.1007/s12016-014-8427-x.
   PubMed Web of Science ®Google Scholar
• Chalifoux SL, Konyn PG, Choi G, et al. Extrahepatic manifestations of primary biliary cholangitis. Gut Liver. 2017;11(6):771–780. doi: 10.5009/gnl16365.
   PubMed Web of Science ®Google Scholar
• Parés A, Rimola A, Bruguera M, et al. Renal tubular acidosis in primary biliary cirrhosis. Gastroenterology. 1981;80(4):681–686.
   PubMed Web of Science ®Google Scholar
• Burnevich EZ, Lopatkina TN. System manifestations of primary biliary cirrhosis. Klin Med (Mosk). 2006;84(12):42–46.
   PubMedGoogle Scholar
• Zimmermann J, Harendza S, Noriega M, et al. Membranous nephropathy and primary biliary cholangitis: a case report and review of the literature. Clin Nephrol. 2021;96(1):36–45. doi: 10.5414/CN110363.
   PubMed Web of Science ®Google Scholar
• Yamashita H, Suzuki A, Takahashi Y, et al. Anti-neutrophil cytoplasmic antibody (ANCA)-associated vasculitis associated with primary biliary cirrhosis: a case report and literature review. Intern Med. 2015;54(10):1303–1308. doi: 10.2169/internalmedicine.54.3678.
   PubMed Web of Science ®Google Scholar
• Vitali C, Bombardieri S, Jonsson R, et al. Classification criteria for sjogren’s syndrome: a revised version of the European criteria proposed by the American-European consensus group. Ann Rheum Dis. 2002;61(6):554–558. doi: 10.1136/ard.61.6.554.
   PubMed Web of Science ®Google Scholar
• Messiaen T, Deret S, Mougenot B, et al. Adult fanconi syndrome secondary to light chain gammopathy. Clinicopathologic heterogeneity and unusual features in 11 patients. Medicine (Baltimore). 2000;79(3):135–154. doi: 10.1097/00005792-200005000-00002.
   PubMed Web of Science ®Google Scholar
• Vignon M, Javaugue V, Alexander MP, et al. Current anti-myeloma therapies in renal manifestations of monoclonal light chain-associated Fanconi syndrome: a retrospective series of 49 patients. Leukemia. 2017;31(1):123–129. doi: 10.1038/leu.2016.195.
   PubMed Web of Science ®Google Scholar
• Shi X, Chen Z, Wang J, et al. Primary sjӧgren’s syndrome with renal fanconi syndrome: good responses to treatment with glucocorticoids. Semin Arthritis Rheum. 2020;50(6):1326–1332. doi: 10.1016/j.semarthrit.2020.03.017.
   PubMed Web of Science ®Google Scholar
• Nakayama A, Matsuo H, Ohtahara A, et al. Clinical practice guideline for renal hypouricemia (1st edition). Hum Cell. 2019;32(2):83–87. doi: 10.1007/s13577-019-00239-3.
   PubMed Web of Science ®Google Scholar
• Gilbert SJ, Weiner DE, Gipson DS, et al. National kidney foundation’s primer on kidney diseases. 6th ed. New York: Elsevier; 2014.
   Google Scholar
• Payne RB. Renal tubular reabsorption of phosphate (TmP/GFR): indications and interpretation. Ann Clin Biochem. 1998;35 (Pt 2)(2):201–206. doi: 10.1177/000456329803500203.
   PubMedGoogle Scholar
• Ram R, Swarnalatha G, Dakshinamurty KV. Renal tubular acidosis in sjogren’s syndrome: a case series. Am J Nephrol. 2014;40(2):123–130. doi: 10.1159/000365199.
   PubMed Web of Science ®Google Scholar
• Rodríguez Soriano J. Renal tubular acidosis: the clinical entity. J Am Soc Nephrol. 2002;13(8):2160–2170. doi: 10.1097/01.ASN.0000023430.92674.E5.
   PubMed Web of Science ®Google Scholar
• Hirschfield GM, Dyson JK, Alexander GJM, et al. The british society of gastroenterology/UK-PBC primary biliary cholangitis treatment and management guidelines. Gut. 2018;67(9):1568–1594. doi: 10.1136/gutjnl-2017-315259.
   PubMed Web of Science ®Google Scholar
• Izumi N, Hasumura Y, Takeuchi J. Hypouricemia and hyperuricosuria as expressions of renal tubular damage in primary biliary cirrhosis. Hepatology. 1983;3(5):719–723. doi: 10.1002/hep.1840030516.
   PubMed Web of Science ®Google Scholar
• Kamouchi M, Tsuji H, Hirakata H, et al. Tubulointerstitial disorders in the kidney associated with primary biliary cirrhosis (PBC). Clin Nephrol. 1991;35(3):134–135.
   PubMed Web of Science ®Google Scholar
• Kodama T, Imai H, Wakui H, et al. Tubulointerstitial nephritis with renal tubular acidosis and asymptomatic primary biliary cirrhosis accompanied by antibody to a 52-kDa mitochondrial protein alone. Clin Nephrol. 1996;45(6):401–405.
   PubMed Web of Science ®Google Scholar
• Davidson BK, Haslock I. Osteomalacia secondary to renal tubular acidosis masquerading as primary biliary cirrhosis. Rheumatology (Oxford). 2000;39(12):1428–1429. doi: 10.1093/rheumatology/39.12.1428.
   PubMed Web of Science ®Google Scholar
• Lino M, Binaut R, Noël LH, et al. Tubulointerstitial nephritis and fanconi syndrome in primary biliary cirrhosis. Am J Kidney Dis. 2005;46(3):e41-6–e46. doi: 10.1053/j.ajkd.2005.05.021.
   PubMed Web of Science ®Google Scholar
• Terrier B, Fakhouri F, Berezne A, et al. Osteomalacia revealing celiac disease and primary biliary cirrhosis-related fanconi syndrome in a patient with systemic sclerosis. Clin Exp Rheumatol. 2008;26:467–470.
   PubMed Web of Science ®Google Scholar
• Bando H, Hashimoto N, Hirota Y, et al. Severe hypophosphatemic osteomalacia with fanconi syndrome, renal tubular acidosis, vitamin D deficiency and primary biliary cirrhosis. Intern Med. 2009;48(5):353–358. doi: 10.2169/internalmedicine.48.1644.
   PubMed Web of Science ®Google Scholar
• Komatsuda A, Wakui H, Ohtani H, et al. Tubulointerstitial nephritis and renal tubular acidosis of different types are rare but important complications of primary biliary cirrhosis. Nephrol Dial Transplant. 2010;25(11):3575–3579. doi: 10.1093/ndt/gfq232.
   PubMed Web of Science ®Google Scholar
• Yamaguchi S, Maruyama T, Wakino S, et al. A case of severe osteomalacia caused by tubulointerstitial nephritis with Fanconi syndrome in asymptomotic primary biliary cirrhosis. BMC Nephrol. 2015;16(1):187. doi: 10.1186/s12882-015-0184-4.
   PubMedGoogle Scholar
• Takahashi N, Saeki T, Komatsuda A, et al. Tubulointerstitial nephritis with IgM-positive plasma cells. J Am Soc Nephrol. 2017;28(12):3688–3698. doi: 10.1681/ASN.2016101074.
   PubMed Web of Science ®Google Scholar
• Mizoguchi S, Katayama K, Murata T, et al. IgM-positive tubulointerstitial nephritis associated with asymptomatic primary biliary cirrhosis. Kidney Int Rep. 2018;3(4):1004–1009. doi: 10.1016/j.ekir.2018.04.001.
   PubMed Web of Science ®Google Scholar
• Akagi R, Ishii A, Kaneko K, et al. A report of three cases of patients with tubulointerstitial nephritis with IgM-positive plasma cells, treatment, and serum-IgM as a sensitive marker for relapse. BMC Nephrol. 2023;24(1):201. doi: 10.1186/s12882-023-03253-8.
   PubMed Web of Science ®Google Scholar
• Er C, Dyson J, Jones D, et al. Primary biliary cholangitis presenting with Fanconi syndrome: an important phenotype. BMJ Case Rep. 2022;15(8):e248461. doi: 10.1136/bcr-2021-248461.
   PubMedGoogle Scholar
• Blanchard A, Bockenhauer D, Bolignano D, et al. Gitelman syndrome: consensus and guidance from a kidney disease: improving global outcomes (KDIGO) controversies conference. Kidney Int. 2017;91(1):24–33. doi: 10.1016/j.kint.2016.09.046.
   PubMed Web of Science ®Google Scholar
• Konrad M, Nijenhuis T, Ariceta G, et al. Diagnosis and management of bartter syndrome: executive summary of the consensus and recommendations from the European Rare Kidney Disease Reference Network Working Group for Tubular Disorders. Kidney Int. 2021;99(2):324–335. doi: 10.1016/j.kint.2020.10.035.
   PubMed Web of Science ®Google Scholar
• Kim YK, Song HC, Kim WY, et al. Acquired gitelman syndrome in a patient with primary sjögren syndrome. Am J Kidney Dis. 2008;52(6):1163–1167. doi: 10.1053/j.ajkd.2008.07.025.
   PubMed Web of Science ®Google Scholar
• Gu X, Su Z, Chen M, et al. Acquired gitelman syndrome in a primary sjögren syndrome patient with a SLC12A3 heterozygous mutation: a case report and literature review. Nephrology (Carlton). 2017;22(8):652–655. doi: 10.1111/nep.13045.
   PubMed Web of Science ®Google Scholar
• Fraj A, El Euch M, Jaziri F, et al. Acquired bartter syndrome in primary sjögren syndrome. Saudi J Kidney Dis Transpl. 2020;31(5):1144–1147. doi: 10.4103/1319-2442.301185.
   PubMedGoogle Scholar
• Barathidasan GS, Krishnamurthy S, Karunakar P, et al. Systemic lupus erythematosus complicated by a gitelman-like syndrome in an 8-year-old girl. CEN Case Rep. 2020;9(2):129–132. doi: 10.1007/s13730-019-00440-1.
   PubMed Web of Science ®Google Scholar
• Silveira MAD, Seguro AC, Gomes SA, et al. Distal renal tubular acidosis associated with autoimmune diseases: reports of 3 cases and review of mechanisms. Am J Case Rep. 2022;23:e933957. doi: 10.12659/AJCR.933957.
   PubMed Web of Science ®Google Scholar
• Tsantoulas DC, McFarlane IG, Portmann B, et al. Cell-mediated immunity to human Tamm-Horsfall glycoprotein in autoimmune liver disease with renal tubular acidosis. Br Med J. 1974;4(5943):491–494. doi: 10.1136/bmj.4.5943.491.
   PubMedGoogle Scholar
• Sakaguchi K, Koide N, Kondow H, et al. Hepatocyte plasma membrane antigens. II. Characterization of liver-specific membrane lipoprotein (LP-1) and Tamm-Horsfall glycoprotein (THGP) like antigens (hepatic THGP) on the plasma membrane of chang liver cell. Gastroenterol Jpn. 1983;18(4):339–345. doi: 10.1007/BF02774951.
   PubMedGoogle Scholar
• Grünfeld JP, Niaudet P, Rötig A. Renal involvement in mitochondrial cytopathies. Nephrol Dial Transplant. 1996;11(5):760–761. doi: 10.1093/oxfordjournals.ndt.a027391.
   PubMed Web of Science ®Google Scholar
• Cez A, Brocheriou I, Lescure F-X, et al. Decreased expression of megalin and cubilin and altered mitochondrial activity in tenofovir nephrotoxicity. Hum Pathol. 2018;73:89–101. doi: 10.1016/j.humpath.2017.12.018.
   PubMed Web of Science ®Google Scholar
• Solís Herruzo JA, Solís Muñoz P, Muñoz Yagüe T. The pathogenesis of primary biliary cirrhosis. Revista Espanola de Enfermedades Digestivas: organo Oficial de la Sociedad Espanola de Patologia Digestiva. 2009;101:413–423.
   PubMed Web of Science ®Google Scholar
• Deng X, Li J, Hou S, et al. Prevalence and impact of sjögren’s syndrome in primary biliary cholangitis: a systematic review and meta-analysis. Ann Hepatol. 2022;27(6):100746. doi: 10.1016/j.aohep.2022.100746.
   PubMed Web of Science ®Google Scholar
• Sun Y, Zhang W, Li B, et al. The coexistence of sjögren’s syndrome and primary biliary cirrhosis: a comprehensive review. Clin Rev Allergy Immunol. 2015;48(2-3):301–315. doi: 10.1007/s12016-015-8471-1.
   PubMed Web of Science ®Google Scholar
• Selmi C, Meroni PL, Gershwin ME. Primary biliary cirrhosis and sjögren’s syndrome: autoimmune epithelitis. J Autoimmun. 2012;39(1-2):34–42. doi: 10.1016/j.jaut.2011.11.005.
   PubMed Web of Science ®Google Scholar